$NEOV
NeoVolta Inc.

2022 Q4 Form 10-Q Financial Statement

#000168316822007520 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $567.1K $1.538M $1.600M
YoY Change -45.21% -3.86%
Cost Of Revenue $473.2K $1.292M $1.361M
YoY Change -45.09% -5.07%
Gross Profit $93.95K $245.9K $238.6K
YoY Change -45.83% 3.05%
Gross Profit Margin 16.57% 15.99% 14.92%
Selling, General & Admin $1.074M $919.4K $360.0K
YoY Change -74.05% 155.4%
% of Gross Profit 1142.92% 373.94% 150.87%
Research & Development $7.746K $20.90K $4.253K
YoY Change -87.56% 391.42%
% of Gross Profit 8.25% 8.5% 1.78%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.081M $940.3K $360.8K
YoY Change -74.25% 160.62%
Operating Profit -$987.5K -$694.5K -$122.2K
YoY Change -75.47% 468.29%
Interest Expense $0.00 $4.134K $561.00
YoY Change -100.0% 636.9%
% of Operating Profit
Other Income/Expense, Net $0.00 -$4.134K -$561.00
YoY Change -100.0% 636.9%
Pretax Income -$987.5K -$698.6K -$130.0K
YoY Change -75.49% 437.38%
Income Tax
% Of Pretax Income
Net Earnings -$987.5K -$698.6K -$122.8K
YoY Change -75.49% 469.06%
Net Earnings / Revenue -174.14% -45.43% -7.67%
Basic Earnings Per Share -$0.03 -$0.02 -$0.01
Diluted Earnings Per Share -$0.03 -$0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 32.85M shares 32.77M shares 19.97M shares
Diluted Shares Outstanding 32.82M shares 29.01M shares 19.97M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.423M $3.993M
YoY Change
Cash & Equivalents $3.423M $3.993M $238.2K
Short-Term Investments
Other Short-Term Assets $276.5K $107.5K
YoY Change
Inventory $1.739M $1.637M
Prepaid Expenses
Receivables $1.811M $2.076M
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.249M $7.813M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $7.249M $7.813M
Total Long-Term Assets $0.00 $0.00
Total Assets $7.249M $7.813M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.61K $0.00
YoY Change
Accrued Expenses $17.76K $342.7K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change
Total Short-Term Liabilities $47.37K $342.6K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $47.37K $342.6K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $47.37K $342.6K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$17.49M -$16.50M
YoY Change
Common Stock $32.85K $32.77K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.202M $7.470M $3.116M
YoY Change
Total Liabilities & Shareholders Equity $7.249M $7.813M
YoY Change

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$987.5K -$698.6K -$122.8K
YoY Change -75.49% 469.06%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$570.0K -$118.1K -$187.5K
YoY Change 19.76% -37.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $3.780M $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -570.0K -$118.1K -$187.5K
Cash From Investing Activities
Cash From Financing Activities 0.000 $3.780M $0.00
Net Change In Cash -570.0K $3.662M -$187.5K
YoY Change -196.26% -2053.0%
FREE CASH FLOW
Cash From Operating Activities -$570.0K -$118.1K -$187.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001748137
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
001-41447
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
NeoVolta, Inc.
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5299263
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
13651 Danielson Street
CY2022Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Poway
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92064
CY2022Q3 dei City Area Code
CityAreaCode
(800)
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
364-5464
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32845368 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3992651 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
330385 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2075956 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1317738 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1636651 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2238208 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
107532 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
239001 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
7812790 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
4125332 usd
CY2022Q3 us-gaap Assets
Assets
7812790 usd
CY2022Q2 us-gaap Assets
Assets
4125332 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
205600 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
0 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
53436 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
342645 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
127356 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1068000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
342645 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1454392 usd
CY2022Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2022Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
53716 usd
CY2022Q3 us-gaap Liabilities
Liabilities
342645 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1508108 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32770368 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32770368 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21977251 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21977251 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
32771 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
21978 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23935355 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18394641 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16497981 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15799395 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7470145 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2617224 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7812790 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4125332 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1537836 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1599604 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1291960 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1360994 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
245876 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
238610 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
919428 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
356558 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20900 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4253 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
940328 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
360811 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-694452 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-122201 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
4134 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
561 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4134 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-561 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-698586 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-122762 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29009882 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29009882 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19966020 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19966020 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2617224 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3780405 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1179286 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
591816 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-698586 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7470145 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3148634 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1283 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
130623 usd
CY2021Q3 NEOV Adjustment For Change In Accounting Principle
AdjustmentForChangeInAccountingPrinciple
41307 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-122762 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3116471 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-698586 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-122762 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
591816 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
130623 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
758218 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
471989 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-601557 usd
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-224618 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
-131469 usd
CY2021Q3 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
-27555 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-205600 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21030 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
219423 usd
CY2021Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3405 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-118139 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-187520 usd
CY2022Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
3780405 usd
CY2021Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3780405 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3662266 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-187520 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
330385 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
425681 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3992651 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238161 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q3 NEOV Conversion Of Convertible Debt And Accrued Interest Into Common Stock
ConversionOfConvertibleDebtAndAccruedInterestIntoCommonStock
1179286 usd
CY2021Q3 NEOV Conversion Of Convertible Debt And Accrued Interest Into Common Stock
ConversionOfConvertibleDebtAndAccruedInterestIntoCommonStock
1283 usd
CY2022Q3 NEOV Adjustment Of Debt Discount Related To Adoption Of New Accounting Principle
AdjustmentOfDebtDiscountRelatedToAdoptionOfNewAccountingPrinciple
0 usd
CY2021Q3 NEOV Adjustment Of Debt Discount Related To Adoption Of New Accounting Principle
AdjustmentOfDebtDiscountRelatedToAdoptionOfNewAccountingPrinciple
87116 usd
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
3742651 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1548113 usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1844049 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
88538 usd
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
22768 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
371391 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1636651 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2238208 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2022Q3 us-gaap Revenue Recognition Allowances
RevenueRecognitionAllowances
<p id="xdx_84C_eus-gaap--RevenueRecognitionAllowances_zq8G0lCQuJMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86A_zEE5cW4hc1Fj">Allowance for Doubtful Accounts</span></i> – The Company recognizes an allowance for doubtful accounts whenever a loss is expected to be incurred in the realization of a customer’s account. As of September 30, 2022 and June 30, 2022, <span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20220930_zD9F82bvdszc" title="Allowance for doubtful accounts"><span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20220630_z0oqTBmaTlIb" title="Allowance for doubtful accounts">no</span></span> allowance for doubtful accounts has been recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_z0lj0o4DhNP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_862_z50xNf4PLrC1">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0 usd
CY2022Q3 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
59251 usd
CY2022Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
9404867 shares
CY2022Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0063
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.00
CY2021Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1283 usd
CY2021Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
203630 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2022Q3 NEOV Warrants Issued To Public Investors
WarrantsIssuedToPublicInvestors
1121250 shares
CY2022Q3 NEOV Weighted Average Exercise Price Warrants Issued To Public Investors
WeightedAverageExercisePriceWarrantsIssuedToPublicInvestors
4.00
CY2022Q3 NEOV Warrants Issued To Underwriters
WarrantsIssuedToUnderwriters
58500 shares
CY2022Q3 NEOV Weighted Average Exercise Price Warrants Issued To Underwriters
WeightedAverageExercisePriceWarrantsIssuedToUnderwriters
4.40
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1179750 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.02
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M18D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1191548 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1179750 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.02
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1191548 usd
CY2022Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
591816 usd

Files In Submission

Name View Source Status
0001683168-22-007520-index-headers.html Edgar Link pending
0001683168-22-007520-index.html Edgar Link pending
0001683168-22-007520.txt Edgar Link pending
0001683168-22-007520-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
neov-20220930.xsd Edgar Link pending
neovolta_ex1013.htm Edgar Link pending
neovolta_ex3101.htm Edgar Link pending
neovolta_ex3102.htm Edgar Link pending
neovolta_ex3201.htm Edgar Link pending
neovolta_ex3202.htm Edgar Link pending
neovolta_i10q-093022.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
neov-20220930_cal.xml Edgar Link unprocessable
neov-20220930_def.xml Edgar Link unprocessable
neov-20220930_lab.xml Edgar Link unprocessable
neov-20220930_pre.xml Edgar Link unprocessable
neovolta_i10q-093022_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending